<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02388802</url>
  </required_header>
  <id_info>
    <org_study_id>1</org_study_id>
    <nct_id>NCT02388802</nct_id>
  </id_info>
  <brief_title>Human Clinical Trial of Uterine Transplantation in the United Kingdom</brief_title>
  <official_title>The First Human Clinical Trial of Uterine Transplantation in the United Kingdom</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Womb Transplant UK</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Womb Transplant UK</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ten patients will undergo uterine transplantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ten patients that will be appropriately selected using a variety of physical and
      psychological assessments. The selected patients will undergo egg retrieval and subsequent
      freezing of embryos to enable IVF treatment following transplantation. Following uterine
      transplantation, using deceased donor allografts, the patients will be closely monitored for
      12 months clinically, radiologically and immunologically until embryo transfer. Following
      successful embryo transfer the patients will continue to be monitored antenatally until they
      are delivered by Caesarean section.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Transplant success</measure>
    <time_frame>12 months</time_frame>
    <description>Efficacy as measured by successful graft transplantation with no clinical, immunological or radiological signs of graft rejection within the first 12 months post-operatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>24 months</time_frame>
    <description>Efficacy as measured by the number of patients successful of conception by IVF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Live birth rate</measure>
    <time_frame>36 months</time_frame>
    <description>Efficacy as measured by the number of live births following successful conception</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Uterine transplant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 patients will be appropriately selected to undergo oocyte retrieval and freezing. Subsequently deceased donor allograft excision will take place prior to uterine transplantation. Immunosuppressive agents will be used to optimise graft success until successful In-vitro fertilisation and subsequent delivery by Caesarean Section</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Oocyte retrieval and freezing</intervention_name>
    <description>10 Patients will undergo oocyte retrieval and freezing</description>
    <arm_group_label>Uterine transplant</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Deceased Donor Allograft Excision</intervention_name>
    <description>Appropriately matched uterine transplant allografts will be excised from deceased donors</description>
    <arm_group_label>Uterine transplant</arm_group_label>
    <other_name>Cadaveric Donor Allograft Excision</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Uterine Transplantation</intervention_name>
    <description>Following egg freezing the patients will undergo uterine transplant from deceased donors</description>
    <arm_group_label>Uterine transplant</arm_group_label>
    <other_name>Womb Transplant</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Immunosuppressive Agents</intervention_name>
    <description>Patients will be appropriately immunosuppressed, whilst being closely monitored clinically, radiologically and immunologically.</description>
    <arm_group_label>Uterine transplant</arm_group_label>
    <other_name>Immunosuppressives</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>In-vitro fertilisation</intervention_name>
    <description>12 months after successful transplantation,the patients will undergo IVF</description>
    <arm_group_label>Uterine transplant</arm_group_label>
    <other_name>IVF</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Caesarean Section</intervention_name>
    <description>Following successful conception and antenatal period, the babies will be born by Caesarean Section</description>
    <arm_group_label>Uterine transplant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female

          -  Between 18-36 years of age

          -  Absolute Uterine factor infertility

        Exclusion Criteria:

          -  Poor ovarian reserve - Unsuccessful oocyte retrieval

          -  No intercurrent significant medical or psychiatric co-morbidities

          -  Previous oncology patients &lt;5 years in remission

          -  Outside of age range

          -  Normal BMI
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Smith, FRCOG, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial NHS Healthcare Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benjamin P Jones, MBChB BSc</last_name>
    <phone>+447740358900</phone>
    <email>benjamin.jones@nhs.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Srdjan Saso, MRCS PhD BSc</last_name>
    <phone>+447890795182</phone>
    <email>srdjan.saso01@imperial.ac.uk</email>
  </overall_contact_backup>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2015</study_first_submitted>
  <study_first_submitted_qc>March 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2015</study_first_posted>
  <last_update_submitted>November 7, 2016</last_update_submitted>
  <last_update_submitted_qc>November 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Infertility</keyword>
  <keyword>Transplant</keyword>
  <keyword>IVF</keyword>
  <keyword>Hysterectomy</keyword>
  <keyword>Absolute uterine infertility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Immunosuppressive Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

